Terumo Medical Corporation
Pharmaceutical & medical device company payment data from CMS Open Payments.
Total Payments
$13.5M
Doctors Paid
14,016
Transactions
47,606
2024 Total
$1.6M
Payment Breakdown by Category
Consulting$5.4M (40.4%)
Research$3.9M (29.2%)
Food & Beverage$1.6M (12.1%)
Travel$1.5M (11.4%)
Payments by Nature
| Nature of Payment | Amount | Transactions | Share |
|---|---|---|---|
| Consulting Fee | $5.4M | 3,033 | 40.4% |
| Unspecified | $3.9M | 408 | 29.2% |
| Food and Beverage | $1.6M | 36,942 | 12.1% |
| Travel and Lodging | $1.5M | 6,278 | 11.4% |
| Grant | $304,000 | 24 | 2.3% |
| Space rental or facility fees (teaching hospital only) | $300,467 | 94 | 2.2% |
| Compensation for services other than consulting, including serving as faculty or as a speaker at a venue other than a continuing education program | $177,425 | 76 | 1.3% |
| Education | $146,196 | 746 | 1.1% |
| Honoraria | $8,843 | 5 | 0.1% |
Payments by Type
General
$9.5M
47,198 transactions
Research
$3.9M
408 transactions
Research Studies & Clinical Trials
| Study Name | Total Paid | Doctors | Records |
|---|---|---|---|
| OSPREY ILIAC: OCCLUSIVE/STENOTIC PERIPHERAL ARTERY REVASCULARIZATION STUDY FOR COMMON AND/OR EXTERNAL ILIAC ARTERY USING THE MISAGO RX SELF-EXPANDING PERIPHERAL STENT | $679,757 | 4 | 124 |
| PROSPECTIVE, MULTI-CENTER, OBSERVATIONAL, POST-MARKET STUDY TO ASSESS THE SAFETY AND PROCEDURAL SUCCESS OF PERFORMING TRANSRADIAL ACCESS FOR TREATMENT OF ATHEROSCLEROTIC LESIONS IN THE LOWER EXTREMITIES | $378,532 | 0 | 36 |
| NULL | $307,769 | 0 | 11 |
| Cross-Seal IDE | $306,119 | 12 | 57 |
| RAVI | $239,854 | 0 | 27 |
| SAFE STEMI | $175,000 | 0 | 3 |
| PAE EMBO IISR | $123,313 | 0 | 3 |
| PRIME REGISTRY | $120,001 | 0 | 5 |
| RAVI Registry | $91,404 | 0 | 5 |
| Retrospective PAE analysis | $87,424 | 1 | 2 |
| PORTRAIT-CLI PATIENT-CENTERED OUTCOMES RELATED TO TREATMENT PRACTICES IN PERIPHERAL ARTERIAL DISEASE: INVESTIGATOR TRAJECTORIES IN CRITICAL LIMB ISCHEMIA | $80,000 | 0 | 2 |
| PROSPECTIVE, MULTI-CENTER, OBSERVATIONAL, POST-MARKET STUDY TO ASSESS THE SAFETY AND PROCEDURAL SUCCESS OF PERFORMING TRANSRADIAL ACCESS FOR TREATMENT OF ATHEROSCLEROTIC LESIONS IN THE LOWER EXTREMITIES. | $79,024 | 1 | 38 |
| Amin TR PCI | $75,000 | 0 | 6 |
| STUDY OF ACCESS SITE FOR ENHANCING PCI IN STEMI FOR SENIORS (SAFE-STEMI FOR SENIORS) | $75,000 | 0 | 1 |
| R2P Registry | $63,951 | 0 | 5 |
| R2- Retrospective | $54,960 | 1 | 1 |
| SAFETY AND EFFICACY OF USING R2P DESTINATION SLENDER GUIDING SHEATH FOR PERIPHERAL ENDOVASCULAR PROCEDURES | $52,000 | 0 | 3 |
| PORTRAIT CLI | $50,000 | 0 | 2 |
| Ansaarie MaLEI | $48,300 | 0 | 2 |
| The RAVI Registry: A Prospective, Multi-Center, Observational Study of Radial Access Embolization Procedures Using HydroPearl Microspheres | $46,501 | 0 | 16 |
| RETROSPECTIVE ANALYSIS OF PERIPHERAL VASCULAR INTERVENTION PROCEDURAL AND SAFETY OUTCOMES WITH UTILIZATION OF THE TERUMO GLIDESHEATH SLENDER WITH TIBIOPEDAL ACCESS | $45,000 | 0 | 1 |
| THE RAVI REGISTRY: A PROSPECTIVE, MULTI-CENTER, OBSERVATIONAL STUDY OF RADIAL ACCESS EMBOLIZATION PROCEDURES USING HYDROPEARL MICROSPHERES | $44,354 | 0 | 18 |
| IISR - UFE SUCCESS | $39,507 | 0 | 2 |
| UFE Retrospective Analysis | $32,324 | 0 | 2 |
| KANSHAS | $26,011 | 1 | 8 |
| PROSTATIC ARTERY EMBOLIZATION VS MEDICATION FOR BENIGN PROSTATIC HYPERPLASIA: SINGLE SUBJECT STUDY DESIGN | $24,663 | 0 | 1 |
| SURFLASH PLUS | $24,450 | 0 | 2 |
| CLINICAL REGISTRY OF THE ST. JUDE MEDICAL ANGIO-SEAL EVOLUTION FOLLOWING DIAGNOSTIC AND ENTERVENTIONAL ENDOVASCULAR PROCEDURES | $24,219 | 0 | 1 |
| ST. JUDE MEDICAL ANGIO-SEAL VASCULAR CLOSURE DEVICE INTERVENTIONAL RADIOLOGY CLINICAL REGISTRY | $21,354 | 0 | 1 |
| Mustapha Glidesheath Retro Analysis - IISR | $15,000 | 0 | 1 |
Payments by Medical Specialty
Top Paid Doctors
| Doctor | Specialty | Location | Total | 2024 |
|---|---|---|---|---|
| Marcelo Guimaraes, Md, MD | Vascular & Interventional Radiology | Charleston, SC | $512,580 | $0 |
| Edward Lee, Md, MD | Diagnostic Radiology | Los Angeles, CA | $388,942 | $0 |
| Dr. Amit Srivastava, M.d, M.D | Interventional Cardiology | Edgewood, KY | $268,942 | $0 |
| Dr. Ari Isaacson, M.d, M.D | Vascular & Interventional Radiology | Chapel Hill, NC | $233,134 | $0 |
| Mazin Foteh, Md, MD | Vascular Surgery | Austin, TX | $211,072 | $0 |
| Erin Moore, Md, MD | Vascular Surgery | Jacksonville, FL | $180,759 | $0 |
| Dr. Ankur Lodha, M.d, M.D | Cardiovascular Disease | Lafayette, LA | $171,081 | $0 |
| Dr. Neil Resnick, M.d, M.D | Diagnostic Radiology | Worcester, MA | $170,915 | $0 |
| Dr. Sandeep Bagla, M.d, M.D | Vascular & Interventional Radiology | Falls Church, VA | $155,147 | $0 |
| Dr. Navid Eghbalieh, M.d, M.D | Vascular & Interventional Radiology | Los Angeles, CA | $144,199 | $0 |
| Dr. Jihad Mustapha, M.d, M.D | Cardiovascular Disease | Grand Rapids, MI | $121,391 | $0 |
| Srinivasa Potluri, Md, MD | Cardiovascular Disease | Plano, TX | $116,558 | $0 |
| Sameh Sayfo | Internal Medicine | Plano, TX | $113,058 | $0 |
| Fadi Saab, Md, MD | Hospitalist | Grand Rapids, MI | $103,492 | $0 |
| Dr. Vamsi Krishna, M.d, M.D | Interventional Cardiology | Kyle, TX | $95,844 | $0 |
| Dr. Aaron Fischman, M.d, M.D | Diagnostic Radiology | New York, NY | $86,985 | $0 |
| Dr. Imraan Ansaarie, Md, MD | Cardiovascular Disease | East Palatka, FL | $83,387 | $0 |
| Dr. Mohammad Raja, Md, MD | Cardiovascular Disease | El Paso, TX | $79,469 | $0 |
| Edvard Skripochnik, Md, MD | Student in an Organized Health Care Education/Training Program | Bronx, NY | $77,795 | $0 |
| Mark Lessne, Md, MD | Diagnostic Radiology | Charlotte, NC | $76,982 | $0 |
| Dr. Byron Decamp, Md, MD | Vascular Surgery | Lawrence, KS | $75,946 | $0 |
| Dr. Christopher Lesar, M.d, M.D | Vascular Surgery | Chattanooga, TN | $71,505 | $0 |
| William Rollefson, Md, MD | Cardiovascular Disease | Little Rock, AR | $69,384 | $0 |
| Dr. Michael Martinelli, M.d, M.D | Cardiovascular Disease | Albany, NY | $60,421 | $0 |
| Dr. Antonios Gasparis, M.d, M.D | Vascular Surgery | Huntington, NY | $57,296 | $0 |
Ad
Top Products
- Navicross $2.2M
- AZUR CX DETACHABLE $1.1M
Associated Products (25)
- Navicross $2.2M
- AZUR CX DETACHABLE $1.1M
- GLIDESHEATH SLENDER $886,455
- Glidesheath $747,178
- OPTITORQUE $684,005
- Optitorque $633,281
- NAVICROSS $445,839
- AZUR $369,623
- TR Band $280,758
- GLIDEWIRE $276,754
- TR BAND $229,297
- ANGIO-SEAL $214,040
- HydroPearl $195,460
- Azur CX Detachable $176,192
- Misago $134,200
- HYDROPEARL $112,052
- HEARTRAIL $86,804
- AngioSeal $72,785
- METACROSS OTW $65,092
- MetaCross $63,181
- R2P MISAGO $54,799
- VADO $49,595
- GlideWire $33,907
- SurFlash $24,450
- NAGARE $16,869
Payment Categories
- Food & Beverage $1.6M
- Consulting $5.4M
- Travel & Lodging $1.5M
- Research $3.9M
About Terumo Medical Corporation
Terumo Medical Corporation has made $13.5M in payments to 14,016 healthcare providers, recorded across 47,606 transactions in the CMS Open Payments database. In 2024, the company paid $1.6M. The top product by payment volume is Navicross ($2.2M).
Payments were distributed across 144 medical specialties. The top specialty by payment amount is Vascular & Interventional Radiology ($2.1M to 1,167 doctors).
Payment categories include: Food & Beverage ($1.6M), Consulting ($5.4M), Research ($3.9M), Travel & Lodging ($1.5M).
Terumo Medical Corporation is associated with 25 products in the CMS Open Payments database, including Navicross, AZUR CX DETACHABLE, and GLIDESHEATH SLENDER.